Small cell carcinoma of the urinary bladder

Histology and Histopathology

Volumn 25, Issue 2, 2010, Pages 217-221

  Pant Purohit, Mukta ^a   Lopez Beltran, Antonio ^b   Montironi, Rodolfo ^c   MacLennan, Gregory T ^d   Cheng, Liang ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differential diagnosis; Molecular genetics; Neoplasms small cell carcinoma; Prognosis 7; Urinary bladder

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BLADDER TUMOR; FEMALE; GENETICS; HUMAN; MALE; METASTASIS; MORTALITY; PATHOLOGY; REVIEW; RISK FACTOR; SMALL CELL CARCINOMA; TREATMENT OUTCOME; UROLOGIC SURGERY;

CARCINOMA, SMALL CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROGENITAL SURGICAL PROCEDURES;

EID: 75149192032     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Abbas F., Civantos F., Benedetto P. and Soloway M.S. (1995). Small cell carcinoma of the bladder and prostate. Urology 46, 617-630.
2. Abbosh P.H., Wang M., Eble, J.N., Lopez-Beltran A., Maclennan G.T., Montironi R., Zheng S., Pan, C.X., Zhou H. and Cheng L. (2008). Hypermethylation of tumor-suppressor gene cpg islands in small-cell carcinoma of the urinary bladder. Mod. Pathol. 21, 355-362.
3. Abrahams N.A., Moran C., Reyes A.O., Siefker-Radtke A. and Ayala A.G. (2005). Small cell carcinoma of the bladder: A contemporary clinicopathological study of 51 cases. Histopathology 46, 57-63.
4. Alijo Serrano F., Sánchez-Mora N., Angel Arranz J., Hernández C. and Alvarez-Fernández E. (2007). Large cell and small cell neuroendocrine bladder carcinoma: Immunohistochemical and outcome study in a single institution. Am. J. Clin. Pathol. 128, 733-739.
5. Barrington J.W., Fulford S., Griffiths D. and Stephenson T.P. (1997). Tumors in bladder remnant after augmentation enterocystoplasty. J. Urol. 157, 482-485.
6. Black P.C., Agarwal P.K. and Dinney C.P. (2007). Targeted therapies in bladder cancer - an update. Urol. Oncol. 25, 433-438.
7. Blomjous C.E., Vos W., De Voogt H.J., Van der Valk P. and Meijer C.J. (1989). Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 64, 1347-1357.
8. Cheng L., Leibovich B., Cheville J., Ramnani D., Sebo T., Neumann R., Nascimento A., Zincke H. and Bostwick D. (2000). Paraganglioma of the urinary bladder: Can biologic potential be predicted? Cancer 88, 844-852.
9. Cheng L., Pan C.X., Yang X.J., Lopez-Beltran A., MacLennan G.T., Lin H., Kuzel T.M., Papavero V., Tretiakova M., Nigro K., Koch M.O. and Eble J.N. (2004). Small cell carcinoma of the urinary bladder: A clinicopathologic analysis of 64 patients. Cancer 101, 957-962.
10. Cheng L., Jones T.D., McCarthy R.P., Eble J.N., Wang M., MacLennan G.T., Lopez-Beltran A., Yang X.J., Koch M.O., Zhang S., Pan C.X. and Baldridge L.A. (2005). Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am. J. Pathol. 166, 1533-1539.
11. Cheng L., Lopez-Beltran A., MacLennan G.T., Montironi R. and Bostwick D.G. (2008). Neoplasms of the urinary bladder. In: Urologic surgical pathology. 2 ed. Bostwick D.G. and Cheng L. (eds). Elsevier/Mosby. Philadelphia. pp 259-352.
12. Choong N.W., Quevedo J.F. and Kaur J.S. (2005). Small cell carcinoma of the urinary bladder. The mayo clinic experience. Cancer 103, 1172-1178.
13. Dy G.K., Miller A.A., Mandrekar S.J., Aubry M.C., Langdon R.M. Jr, Morton R.F., Schild S.E., Jett J.R. and Adjei A.A. (2005). A phase ii trial of imatinib (st1571) in patients with c-kit expressing relapsed small-cell lung cancer: A calgb and ncctg study. Ann. Oncol. 16, 1811-1816.
14. Fujii H., Aotake T., Horiuchi T., Chiba Y., Imamura Y. and Tanaka K. (2001). Small cell carcinoma of the gallbladder: A case report and review of 53 cases in the literature. Hepatogastroenterology 48, 1588-1593.
15. Fukui T., Tsuta K., Furuta K., Watanabe S., Asamura H., Ohe Y., Maeshima A.M., Shibata T., Masuda N. and Matsuno Y. (2007). Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung. Cancer Sci. 98, 1714-1719.
16. Gnepp D.R. and Wick M.R. (1990). Small cell carcinoma of the major salivary glands. An immunohistochemical study. Cancer 66, 185-192.
17. Grignon D.J., Ro J.Y., Ayala A.G., Shum D.T., Ordonez N.G., Logothetis C.J., Johnson D.E. and Mackay B. (1992). Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer 69, 527-536.
18. Heymach J.V., Johnson D.H., Khuri F.R., Safran H., Schlabach L.L., Yunus F., DeVore R.F. 3rd, De Porre P.M., Richards H.M., Jia X., Zhang S. and Johnson B.E. (2004). Phase ii study of the farnesyl transferase inhibitor r115777 in patients with sensitive relapse smallcell lung cancer. Ann. Oncol. 15, 1187-1193.
19. Higashiyama M., Doi O., Kodama K., Yokouchi H. and Tateishi R. (1995). High prevalence of bcl-2 oncoprotein expression in small cell lung cancer. Anticancer Res 15, 503-505.
20. Holmang S., Borghede G. and Johansson S.L. (1995). Primary small cell carcinoma of the bladder: A report of 25 cases. J. Urol. 153, 1820-1822.
21. Jiang J., Ulbright T.M., Younge C., Sanchez K., Bostwick D.G., Koch M.O., Eble J.N. and Cheng L. (2001). Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Arch. Pathol. Lab. Med. 125, 921-923.
22. Jiang S.X., Sato Y., Kuwao S. and Kameya T. (1995). Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J. Pathol. 177, 135-138.
23. Kitada S., Takayama S., De Riel K., Tanaka S. and Reed J.C. (1994). Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Res. Dev. 4, 71-79.
24. Leonard C., Huret J.L., Gfco and Groupe francais de cytogenetique, o. (2002). From cytogenetics to cytogenomics of bladder cancers. Bull. Cancer 89, 166-173.
25. Lohrisch C., Murray N., Pickles T. and Sullivan L. (1999). Small cell carcinoma of the bladder: Long term outcome with integrated chemoradiation. Cancer 86, 2346-2352.
26. Molina J.R. Adjel A. (2006). Ras/raf/mapk pathway. J. Thoracic Oncol. 1, 7-9.
27. Morinaga R., Okamoto I., Furuta K., Kawano Y., Sekijima M., Dote K., Satou T., Nishio K., Fukuoka M. and Nakagawa K. (2007). Sequential occurrence of non-small cell and small cell lung cancer with the same egfr mutation. Lung Cancer 58, 411-413.
28. Okamoto I., Araki J., Suto R., Shimada M., Nakagawa K. and Fukuoka M. (2006). Egfr mutation in gefitinib-responsive small-cell lung cancer. Ann. Oncol. 17, 1028-1029.
29. Pan C.X., Zhang H., Lara P.N.J. and Cheng L. (2000). Small-cell carcinoma of the urinary bladder: Diagnosis and management. Expert Rev. Anticancer Ther. 6, 1707-1713.
30. Partanen S. and Asikainen U. (1985). Oat cell carcinoma of the urinary bladder with ectopic adrenocorticotropic hormone production. Hum. Pathol. 16, 313-315.
31. Porto D.P., Wick M.R., Ewing S.L. and Adams G.L. (1987). Neuroendocrine carcinoma of the larynx. Am. J. Otolaryngol. 8, 97-104.
32. Pujol J.L., Breton J.L., Gervais R., Tanguy M.L., Quoix E., David P., Janicot H., Westeel V., Gameroff, S., Genève J. and Maraninchi D. (2007). Phase iii double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: An intergroup study fnclcc cleo04 ifct 00-01. J .Clin. Oncol. 25, 3945-3951.
33. Ready N., Dudek A.Z., Wang X.F. and Vokes E. (2007). Calgb 30306: A phase ii study of cisplatin (c), irinotecan (i) and bevacizumab (b) for untreated extensive stage small cell lung cancer (essclc). Clin. Oncol. 25(8S)(suppl) Abstrac 7563.
34. Sandier A., Dowlati A., Moore D.F.J. and Schiller J.H. (2007). A phase ii study of cisplatin (p) plus etoposide (e) plus bevacizumab (b) for previously untreated extensive stage small cell lung cancer (sclc) (e3501): A trial of the eastern cooperative oncology group. J. Clin. Oncol. 25(18S)(suppl) Abstract 7564.
35. Sarma D.P. (1982). Oat cell carcinoma of the esophagus. J. Surg. Oncol. 19, 145-150.
36. Schmitt, C.A., Rosenthal, C.T. and Lowe, S.W. (2000). Genetic analysis of chemoresistance in primary murine lymphomas. Nat. Med. 6, 1029-1035.
37. Siefker-Radtke A.O., Dinney C.P., Abrahams N.A., Moran C., Shen Y., Pisters L.L., Grossman H.B., Swanson D.A. and Millikan R.E. (2004). Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: A retrospective review of the m. D. Anderson cancer experience. J. Urol. 172, 481-484.
38. Slaton J.W., Millikan R., Inoue K., Karashima T., Czerniak B., Shen Y., Yang Y., Benedict W.F. and Dinney C.P. (2004). Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy. J. Urol. 171, 570-574.
39. Swanson P.E., Brooks R., Pearse H. and Stenzel P. (1988). Small cell carcinoma of urinary bladder. Urology 32, 558-563.
40. Taxy J.B., Ettinger D.S. and Wharam M.D. (1980). Primary small cell carcinoma of the skin. Cancer 46, 2308-2311.
41. Terracciano L., Richter J., Tornillo L., Beffa L., Diener P.A., Maurer R., Gasser T.C., Moch H., Mihatsch M.J. and Sauter G. (1999). Chromosomal imbalances in small cell carcinomas of the urinary bladder. J. Pathol. 189, 230-235.
42. Trias I., Algaba F., Condom E., Espanol I., Segui J., Orsola I., Villavicencio H. and Garcia Del Muro X. (2001). Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur. Urol. 39, 85-90.
43. Yogore M.G. III (1980). Small cell carcinoma of the male breast: Report of a case. Cancer 46, 2308-2311.
44. Yu D.S., Chang S.Y., Wang J., Yang T.H., Cheng C.L., Lee S.S. and Ma C.M. (1990). Small cell carcinoma of the urinary tract. Br J Urol 66, 590-595.
45. Zakowski M.F., Ladanyi M. and Kris M.G. (2006). Egfr mutations in small-cell lung cancers in patients who have never smoked. N. Engl. J. Med .355, 213-215.